By WPG Research Team · Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers.
Last verified: April 15, 2026
Some links on this page are affiliate links. We may earn a commission if you choose a provider through us — at no extra cost to you. This does not change our pricing or analysis. See our full methodology.
Medical disclaimer: This content is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any medication.
MEDVi Pills Reviews 2026: Is It Real Wegovy or a Compounded Tablet?
Before you read anything else
MEDVi Compounded GLP-1 Tablet
A daily dissolvable tablet starting at $249/month. Not FDA-approved as a finished product. This is what most online reviews are about.
MEDVi Wegovy® Pill Route
The real, FDA-approved Wegovy tablet from Novo Nordisk, prescribed via MEDVi at $99/month membership + medication cost. MEDVi does not publish the full all-in total on its main pricing page.
These are two different products with different regulatory status, different evidence bases, and different pricing structures. Confirm which one you are enrolling in before entering payment details.
If you searched “MEDVi pills reviews” or “MEDVi Wegovy pill reviews,” the short answer is this: MEDVi’s “pill” offer means two different things, and that confusion is exactly why this page exists.
Here’s the part most people miss: you can get the same FDA-approved Wegovy pill direct from NovoCare Pharmacy for $149–$299/month with no membership fee. And as of April 2026, Ro now offers Foundayo™ (orforglipron) — a competing FDA-approved GLP-1 pill with no fasting requirement — starting at $149/month plus membership.
We compared every major route to oral GLP-1 medication head-to-head against MEDVi’s two pill products. Below is what we verified, who each path actually fits, and where MEDVi makes sense versus where it doesn’t.
The Pill Path Reality Check: Oral GLP-1 Routes Compared
Assembled from five provider pricing pages, manufacturer terms, and FDA approval records — all verified April 15, 2026. Cells marked est. are calculated estimates; cells marked verified come directly from a primary source.
| MEDVi Compounded Tablet | MEDVi Wegovy Pill Route | NovoCare Direct (Wegovy Pill) | Ro (Wegovy Pill or Foundayo) | |
|---|---|---|---|---|
| What it is | Compounded semaglutide dissolvable tablet | FDA-approved Wegovy pill, prescribed via MEDVi | FDA-approved Wegovy pill direct from Novo Nordisk | FDA-approved Wegovy pill or Foundayo via Ro |
| FDA-approved? | No (verified) | Yes — the Wegovy pill itself | Yes (verified) | Yes (verified) |
| Month 1 cost | $249 (verified) | ~$248 est. ($99 membership + ~$149 med) | $149 (verified, 1.5mg/4mg) | $188 est. ($39 membership + $149 med) |
| Ongoing monthly | ~$369 (third-party reported) | ~$248–$398 est. ($99 + $149–$299) | $149–$299 (verified, dose-dependent) | $223–$448 est. ($74–$149 membership + $149–$299 med) |
| Membership fee | None — bundled (verified) | $99/mo (verified) | None (verified) | $39 first month, then $74/mo annual or $149/mo monthly (verified) |
| Insurance support | No | No | Yes — savings card can drop copay to $25/mo (verified, eligibility required) | Yes — Ro’s insurance concierge (verified) |
| Fasting required? | Varies by formulation | Yes — empty stomach, ≤4oz water, 30-min wait (FDA labeling) | Yes — same FDA labeling | Wegovy pill: yes. Foundayo: no — any time of day, with or without food (verified) |
| Clinical trial efficacy | No published trial data for this specific compounded formulation | ~14% body weight loss over 64 weeks (OASIS 4) | Same OASIS 4 data (same product) | Wegovy pill: ~14% over 64 weeks. Foundayo: ~11% over 72 weeks at highest dose (cross-trial) |
| Best for | Cash-pay readers comfortable with compounded medication who want bundled all-in pricing | Existing MEDVi customers wanting FDA-approved pill on their existing platform | Cheapest published cash-pay route to FDA-approved Wegovy pill | Insured patients, annual-prepay savers, or anyone who can’t do the 30-minute morning fast |
Sources: MEDVi.org and glp.medvi.org product pages; NovoCare Pharmacy price guide; Ro.co/weight-loss/pricing; Ro.co/weight-loss/foundayo; WegovyTerms.com; FDA.gov approval records. MEDVi branded-pill all-in totals are estimates derived from MEDVi’s published $99 membership plus NovoCare medication pricing — verify your exact total at MEDVi checkout.
What we actually verified
MEDVi product navigation and pricing cards (glp.medvi.org). MEDVi cancellation/refund policy (home.medvi.org). NovoCare Pharmacy self-pay PDF price guide. Ro Body pricing page. Ro Foundayo product page. Wegovy official pricing terms (WegovyTerms.com). FDA.gov warning letter database. Trustpilot and ConsumerAffairs review profiles. OASIS 4 trial data (NEJM 2025).Check eligibility for MEDVi’s pill program
Specify which product at intake: compounded or Wegovy pill route.
Is MEDVi’s Pill Real Wegovy — or a Compounded Tablet?
For most people, “MEDVi pill” means the compounded GLP-1 tablet. That’s what MEDVi built its business on, and it’s what most online reviews are talking about. MEDVi now also advertises a Wegovy pill route on its product navigation — and that’s why this query is genuinely ambiguous.
MEDVi Compounded Semaglutide Tablet
A daily dissolvable tablet produced by a compounding pharmacy partner — not by Novo Nordisk. MEDVi lists compounded semaglutide tablets starting at $249/month and compounded tirzepatide tablets starting at $279/month, with pricing bundled into one all-in number (no separate membership fee on this path).
These tablets are not FDA-approved as finished products. They have not gone through the same clinical testing as the Wegovy pill. The FDA does not review compounded medications for safety, effectiveness, or quality before they reach patients. That’s not a scare line — it’s the actual regulatory distinction.
The SNAC absorption question
The FDA-approved Wegovy pill uses a specialized absorption enhancer called SNAC (sodium N-[8-(2-hydroxybenzoyl)amino] caprylate) to get semaglutide through the GI tract. Even with SNAC, oral bioavailability is roughly 1% — which is why the morning fasting protocol exists. Whether compounded oral semaglutide tablets achieve meaningful absorption without comparable engineered absorption technology is an open scientific question. A November 2025 class-action complaint (not a proven finding) alleged that compounded oral tirzepatide tablets have no viable absorption pathway. We are not telling you compounded tablets don’t work. We are telling you the clinical evidence base is fundamentally different from the FDA-approved Wegovy pill.MEDVi Wegovy Pill Route
MEDVi’s product navigation now shows a branded Wegovy pill card listed at “$99 Membership + Medication Cost.” This is the real, FDA-approved oral semaglutide tablet manufactured by Novo Nordisk.
Here’s the issue: MEDVi does not publish the all-in monthly total for this path on its public pricing page. You’ll need to verify your complete cost at checkout. Based on the published $99 membership plus NovoCare’s medication pricing ($149–$299/month depending on dose), our estimate for the all-in range is roughly $248–$398/month. We could not confirm the exact total without completing enrollment.
Why this matters
If you came here searching “MEDVi Wegovy pill reviews,” there’s a real chance you’ve been reading reviews about the compounded tablet without knowing it. Before you share payment details: confirm which product you’re enrolling in. The two paths have different regulatory status, different evidence bases, different pricing structures, and different cancellation implications.See if you qualify for MEDVi’s pill path
Specify which product at intake: compounded or branded Wegovy pill.
How Much Do MEDVi Pills Really Cost?
MEDVi is upfront about compounded tablet pricing. They are less transparent about branded pill pricing. That gap is the biggest buying-friction point on this query, and we’ll close it as much as the public information allows.
Compounded Tablet Pricing — What MEDVi Publishes
MEDVi markets compounded paths as bundled all-in pricing with no separate membership fee:
| Product | First Month | Refills / Ongoing |
|---|---|---|
| Compounded semaglutide tablet | $249 | ~$369/month (third-party sourcing) |
| Compounded tirzepatide tablet | $279 | ~$399/month |
| Compounded semaglutide injection | $179 (verified) | $299/month (verified) |
| Compounded tirzepatide injection | $349 | Verify at checkout |
Brand-Name Wegovy Pill Pricing — What’s Public, What’s Not
MEDVi lists “$99 Membership + Medication Cost” for the Wegovy pill route. The medication itself follows Novo Nordisk’s NovoCare pricing:
| Wegovy Pill Dose | NovoCare Price | MEDVi All-In Estimate |
|---|---|---|
| 1.5mg and 4mg (starter doses) | $149/month through Aug 31, 2026 | ~$248/month est. |
| 4mg after August 31, 2026 | $199/month | ~$298/month est. |
| 9mg and 25mg (maintenance) | $299/month | ~$398/month est. |
The August 2026 price change
The August 2026 cutoff is real. If you start on the 4mg dose and you’re still there after August 31, your medication cost increases by $50/month. Novo Nordisk has announced a list-price cut to $675/month starting January 1, 2027 — but that affects insurance calculations, not the NovoCare self-pay pricing this estimate is built on.The 12-Month Cost Math
The Wegovy pill titration schedule per Novo Nordisk is 4 weeks at 1.5mg, 4 weeks at 4mg, 4 weeks at 9mg, then 25mg maintenance — most patients reach maintenance dose by month 4. Modeling 12 months at this schedule:
| Route | Estimated 12-Month Cost | Notes |
|---|---|---|
| NovoCare Direct (Wegovy pill, no membership) | ~$3,288/year | Cheapest cash-pay FDA-approved path |
| Ro Wegovy Pill (annual-prepay membership) | ~$4,141/year | With insurance at $25/mo copay: ~$1,153/year |
| MEDVi Compounded Semaglutide Tablet | ~$4,308/year | $249 first month + $369 × 11 refill months |
| MEDVi Wegovy Pill Route (membership added) | ~$4,476/year | $3,288 medication + $99 × 12 months membership |
Read that last number carefully
MEDVi’s compounded semaglutide tablet (~$4,308/year) costs more annually than the FDA-approved Wegovy pill direct from NovoCare (~$3,288/year). The compounded tablet is not always the budget option people assume — at least not against the brand-name pill bought direct without a membership middleman. These figures use standard titration assumptions and verified per-month pricing. Your actual cost may vary by dose tolerance, plan year, and refill timing.Verify current MEDVi pill pricing
Prices change — confirm at checkout before entering payment details.
What MEDVi Pills Reviews Actually Say (And What They Don’t)
MEDVi has one of the largest review footprints in GLP-1 telehealth. Here’s the data across two independent platforms.
Third-Party Review Snapshot (April 2026)
4.4–4.5 / 5
12,000+ reviews — rated “Excellent”
Includes “Invited” reviews; MEDVi asks customers after positive experiences.
3.4 / 5
~1,860 reviews (updated April 15, 2026)
Attracts more complaint-driven traffic. Gap is real and worth understanding.
Important caveat about review volume
Most of MEDVi’s review volume references the compounded program (their original product line), not the newer branded Wegovy pill path. If you’re researching the branded path specifically, the public review base is much thinner.What People Praise
Positive reviews consistently call out three things: speed of approval, provider responsiveness, and affordability versus brand-name alternatives.
“My weight has been a constantly increasing problem until I found MEDVi. My doctor tried to get me approved for brand-name Wegovy. My insurance said ‘Nope’ — not paying. I searched the internet for options and read so many reviews.”
— Verified ConsumerAffairs reviewer
What People Complain About
Negative reviews cluster around billing and account management. This pattern shows up across Trustpilot, ConsumerAffairs, and Reddit:
“They sign you up at $179, and don’t disclose that it goes up to $299.”
— Reddit user, r/productreview
“I followed MEDVi’s pause process and assumed my subscription would be on hold. Instead, they processed a charge to my card while the account was paused.”
— Will Amory, Trustpilot, April 2026
“After 2.5 months I contacted MEDVi and explained that I had actually gained 3 lbs with their oral GLP-1. They said they were sorry it did not meet my expectations.”
— Kevin O’Sullivan, Trustpilot, April 2026
Note: In the OASIS 4 clinical trial for FDA-approved oral semaglutide, about 24% of participants did not lose 5% or more body weight. For compounded formulations without comparable trial data, the outcome range is wider.
Disclosure: Reviews sourced from independent third-party platforms. We have no ability to edit or remove these. Individual results vary. Testimonials reflect service and billing experience, not medical efficacy claims.
What This Pattern Means for You
The medication side of MEDVi gets mostly positive marks. The billing side gets mixed marks. If you sign up, do three things before entering payment details:
- Screenshot the cancellation policy
- Note the exact date your billing cycle starts
- Confirm in writing which product you’re enrolled in — compounded or branded
Is MEDVi Legit? The FDA Letter, LegitScript, and What It Means
MEDVi is a real telehealth business. That’s not the question. The question is whether it’s transparent enough for your comfort level.
What We Verified
- LegitScript certified (active as of April 2026) — required by major payment processors and ad platforms; fraudulent operations cannot maintain it.
- 12,000+ Trustpilot reviews at 4.4–4.5/5 — one of the largest review footprints in the GLP-1 telehealth space.
- $401 million in 2025 revenue (independently reported by the New York Times).
- “Over 500,000 patients” served (MEDVi’s current company-stated claim).
- Medical care provided through OpenLoop Health and CareGLP affiliated networks of licensed U.S. physicians.
The February 2026 FDA Warning Letter
On February 20, 2026, the FDA published a warning letter to MEDVi, LLC regarding content on the medvi.io domain. The letter cited misbranding — specifically, marketing language that the FDA found falsely implied FDA approval of compounded products and falsely suggested MEDVi was the compounder.
What the letter did NOT say
That MEDVi’s medications were contaminated, unsafe, or improperly made. It addressed promotional claims, not medication safety.
What it IS
A material trust signal you should know about. MEDVi was one of more than 30 telehealth companies warned during a broader enforcement action in early 2026.
Concerns Worth Knowing
OpenLoop Health data security incident (January 2026)
MEDVi’s clinical partner OpenLoop disclosed a cybersecurity incident affecting patient information. The breach happened at OpenLoop, not at MEDVi directly, but MEDVi patients whose care was routed through OpenLoop may be affected. Consider credit monitoring and watch for breach notifications if you’re a current or former MEDVi patient.
Pending litigation
Multiple lawsuits in various stages, none with rulings on the merits. The November 2025 class-action filed against OpenLoop and compounding pharmacy Triad Rx alleges that compounded oral tirzepatide tablets have no viable absorption pathway. Allegations only, not proven findings.
MEDVi’s own on-site testimonials
MEDVi’s website discloses that “certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies” and that “individuals appearing in advertisements may be actors or models.” This is why we anchor this review on third-party Trustpilot and ConsumerAffairs reviews rather than MEDVi’s own marketing testimonials.
When Do You Get Charged — Before or After You Talk to a Provider?
This is one of the most asked questions about MEDVi, and the answer surprises people.
Charge timing: before clinical review
According to MEDVi’s published policy, the subscription begins and the first charge processes when you complete the intake form. That happens before clinical review and before any video visit. If a provider later determines you’re not eligible, MEDVi’s refund handling is a separate process.What this means practically: do not complete the intake form unless you’re ready for the card to be charged. If you want to discuss the program with a provider first, that’s not how MEDVi’s billing flow works.
This is not unique to MEDVi — many telehealth subscription platforms operate the same way. But it catches new users off-guard repeatedly in the reviews, so we’re stating it plainly.
MEDVi Cancellation, Refunds, and the 72-Hour Rule
Billing is the most common complaint theme across review platforms. If you read one section carefully before signing up, make it this one.
The 72-Hour Rule
Set a calendar reminder now
MEDVi’s published policy requires cancellation requests at least 72 hours before your next billing date. Miss that window and you’ll be billed for the next cycle. Set a recurring calendar reminder for 4 days before your billing date. Do not rely on memory.When Refunds Happen
MEDVi’s published policy states that cancellations not due to medical disqualification do not receive refunds, and that medication is non-refundable once shipped.
ConsumerAffairs and other third-party sources have reported a money-back guarantee that requires approximately 5 months of continuous treatment with documented program adherence and a 25% doctor consultation fee withheld. We could not locate this exact guarantee structure on MEDVi’s current cancellation/refund policy page — if it matters to your decision, request the current guarantee terms in writing from MEDVi support before enrolling.
How to Cancel Without Surprises
- 1Screenshot the cancellation policy the day you sign up.
- 2Confirm your exact billing date at intake and set a reminder 4 days before.
- 3Cancel in writing through MEDVi’s portal or email — keep a record.
- 4Get written confirmation that your cancellation was received and processed.
- 5Monitor your card for the next 60 days to catch unexpected charges.
Review MEDVi’s cancellation terms before you sign up
Understand the full policy before entering payment details.
Who Should Choose MEDVi — and Who Should Skip It
We’d rather lose you to the right provider than convert you to the wrong one. Here’s the honest breakdown.
Choose MEDVi’s Compounded Tablet If…
- You’re paying cash and your insurance does not cover GLP-1 medications
- You’ve considered the compounded-vs-FDA-approved distinction and you’re comfortable with a compounded product
- You want bundled all-in pricing with no separate membership fee
- You prefer a daily pill over weekly injections
- The $249/month entry price fits your budget
Choose MEDVi’s Wegovy Pill Route If…
- You specifically want the FDA-approved Wegovy pill
- You’re already a MEDVi customer and want to switch from compounded to branded
- You value having telehealth care and medication managed through one platform
- You’re comfortable paying the $99/month membership on top of medication
- You’ll verify the total at checkout before committing
Skip MEDVi If…
Your insurance covers Wegovy or Foundayo.
Ro’s insurance concierge can pursue coverage on your behalf — when manufacturer savings programs apply, eligible commercially insured patients may pay as little as $25/month for the medication. Ro’s membership is $39 for the first month, then as low as $74/month with annual prepay, and Ro carries Wegovy pill, Zepbound®, and Foundayo™.
You just want the cheapest cash-pay route to FDA-approved Wegovy pill.
NovoCare Pharmacy offers the same pill at $149–$299/month with no membership fee. You’ll need your own prescriber, but the math is clean: NovoCare direct undercuts MEDVi’s branded pill route by roughly $1,200/year on membership alone.
The 30-minute morning fast is a dealbreaker.
The Wegovy pill — through MEDVi or anywhere else — must be taken first thing in the morning on an empty stomach with no more than 4 ounces of plain water, then you wait 30 minutes before eating, drinking anything else, or taking other medications. If that routine doesn’t fit your life, consider Foundayo (orforglipron) through Ro. Foundayo is the only FDA-approved GLP-1 pill that can be taken any time of day, with or without food.
You want full pricing transparency upfront.
MEDVi’s compounded tablet is not FDA-approved, and their branded pill route doesn’t publish a clean all-in total on their main pricing page. If that bothers you (and it reasonably might), choose a platform that publishes complete pricing in advance.
“I Need Coffee First Thing in the Morning”
This is a real question we see in every forum. If your morning starts with coffee and you can’t realistically wait 30 minutes, the FDA-approved Wegovy pill — taken in the morning — won’t work for you as designed. The dosing protocol exists because semaglutide has very low oral bioavailability; without the empty-stomach routine, absorption suffers.
Your options: adjust the routine (most patients say the 30-minute wait becomes habit within a week), switch to a weekly Wegovy injection (no food restrictions), or choose Foundayo (no fasting required, any time of day).
Find your fit with our 60-second matching quiz
We ask about insurance, needle preference, budget, and morning routine — then surface the specific program that fits.
MEDVi vs. FDA-Approved Oral Routes: The Detailed Comparison
For the reader who’s almost ready to act and wants one final comparison.
MEDVi Compounded Tablet vs. Ro Wegovy Pill
MEDVi wins on simplicity: one bundled price, no separate membership fee, fast approval. Ro wins on evidence: FDA-approved product, published clinical trial data, SNAC absorption technology validated in human studies, insurance support through their concierge service. Ro also undercuts MEDVi’s compounded tablet on annual cost for patients on maintenance doses when you factor in published medication pricing plus annual-prepay membership.
MEDVi Branded Wegovy Pill Route vs. Ro Wegovy Pill
This is the same FDA-approved medication through different telehealth platforms. MEDVi charges $99/month membership; Ro charges $39 first month, then $74/month on annual prepay or $149/month on monthly billing. Both add medication cost on top. Ro publishes its full pricing breakdown publicly; MEDVi requires checkout verification. Ro offers an insurance concierge; MEDVi does not.
Wegovy Pill vs. Foundayo: When the Morning Routine Matters
Wegovy pill (semaglutide)
- • ~14% average weight loss over 64 weeks (OASIS 4)
- • Requires empty stomach and 30-minute wait
- • Launched January 2026; 600,000+ prescriptions in first months
- • Available through MEDVi, Ro, NovoCare, GoodRx Care, others
Foundayo™ (orforglipron)
- • ~11% average weight loss over 72 weeks at highest dose (ATTAIN-1)
- • Any time of day, with or without food
- • FDA-approved April 1, 2026 — newest oral GLP-1
- • Currently available through Ro
Cross-trial comparison note
These are cross-trial comparisons, not head-to-head. Wegovy pill delivers more weight loss on average in its trial. Foundayo delivers more flexibility in its dosing protocol. Both carry a boxed warning for thyroid C-cell tumors as a class effect of GLP-1 receptor agonists. Both carry warnings for pancreatitis and gallbladder issues. Both should not be used by people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.Quick Scenario Picker
| If your priority is… | Best route | Why |
|---|---|---|
| Lowest-friction bundled cash-pay tablet | MEDVi compounded tablet | One price, no membership, fast approval |
| Cheapest cash-pay FDA-approved pill | NovoCare direct | $149–$299/mo, no membership fee |
| FDA-approved pill with insurance support | Ro Wegovy pill | Insurance concierge; potential $25/mo copay with savings card |
| FDA-approved pill with no fasting restriction | Ro Foundayo | Only GLP-1 pill that can be taken any time of day |
| Staying with MEDVi but moving to FDA-approved | MEDVi Wegovy pill route | Same platform; verify total at checkout |
Ro (Wegovy pill or Foundayo)
Insurance support, published pricing, no fasting option
See Ro’s Oral GLP-1 OptionsHow Much Weight Can You Expect to Lose?
Clinical data, plainly stated, separated by product.
FDA-Approved Wegovy Pill (OASIS 4 Trial)
~17%
Avg weight loss (completers)
over 64 weeks
~14%
Avg weight loss (all participants)
including discontinuers
76%
Lost 5%+ body weight
28%
Lost 20%+ body weight
Study population: 307 adults with BMI ≥30 (or ≥27 with weight-related comorbidity); type 2 diabetes excluded. Source: Wharton S, et al. New England Journal of Medicine 2025;393:1077-1087.
FDA-Approved Foundayo (ATTAIN-1 Trial)
Average weight loss at the highest dose (17.2 mg): ~11% of body weight over 72 weeks (treatment regimen analysis). Source: Eli Lilly clinical trial program; FDA approval data April 2026.
MEDVi Compounded Semaglutide Tablets
No published clinical trial data
No published clinical trial data exists for MEDVi’s specific compounded tablet formulation. Whether compounded oral semaglutide tablets deliver results comparable to the FDA-approved Wegovy pill has not been established through clinical evidence. Customer-reported outcomes on Trustpilot and Reddit range widely — from significant appetite suppression within 1–2 weeks and 15–30+ pounds lost over 3–6 months, to minimal effect or weight gain (as in the Trustpilot review cited earlier reporting 3 lbs gained after 2.5 months on oral GLP-1).Side Effects: What to Expect
The most common side effects of oral semaglutide are gastrointestinal: nausea, diarrhea, vomiting, constipation, and abdominal pain. These typically peak when starting treatment or increasing dose and improve over time.
Serious side effects are rare but include pancreatitis, gallbladder problems, kidney injury, and a boxed warning for thyroid C-cell tumors (a class effect of GLP-1 receptor agonists). These apply whether you get semaglutide through MEDVi or any other source.
Foundayo carries the same boxed warning for thyroid C-cell tumors and similar GI side effect profile. Patients on oral hormonal contraceptives should add a barrier method or switch to non-oral contraception during Foundayo treatment.
For a comprehensive guide to GLP-1 side effects and how to manage them, see our GLP-1 Side Effects Guide.
Are MEDVi’s Compounded Tablets the Same as the Wegovy Pill?
No. This distinction matters enough for its own section.
The FDA-Approved Wegovy Pill
- Manufactured by Novo Nordisk using a formulation that includes SNAC absorption enhancer
- Went through full FDA approval process — clinical trials, safety review, manufacturing quality standards
- Oral bioavailability ~1% — the morning fasting protocol is engineered to optimize that
MEDVi Compounded Semaglutide Tablet
- Produced by compounding pharmacy partners — not by Novo Nordisk
- Not tested in clinical trials for absorption, safety, or efficacy as finished products
- The FDA explicitly states that compounded drugs do not undergo FDA review before reaching patients
One more thing worth noting
As of April 2026, there is no FDA-approved oral tirzepatide in any form. Tirzepatide is only available as an injection (Mounjaro for diabetes, Zepbound for weight loss). Any “tirzepatide pill” — including MEDVi’s compounded tirzepatide tablet — is a compounded product without FDA approval as a finished oral formulation.For more on the oral GLP-1 landscape, see our Best Oral GLP-1 Provider Guide.
What Happens After You Sign Up With MEDVi
Reducing signup uncertainty is one of the most-requested things in reviews. Here’s the actual process based on MEDVi’s published policies and customer-reported experience.
- 1
Online health assessment
You’ll answer questions about your weight, medical history, medications, and goals.
- 2
Payment
Per MEDVi’s policy, the subscription begins and the first charge processes when you complete the intake form. This happens before clinical review. Plan accordingly.
- 3
Provider review
A licensed clinician through the OpenLoop Health or CareGLP network reviews your information. Some patients report approval without a video visit; others get a virtual consultation. Approval can happen within 24 hours.
- 4
Medication shipped
Compounded tablets ship from a partner pharmacy. No refrigeration required for tablets — an advantage over injectable formulations.
- 5
Ongoing care
MEDVi advertises unlimited doctor visits and 24/7 messaging support. Refills are billed on a recurring cycle — confirm your exact billing date at intake.
- 6
If you want to cancel
See the cancellation section above. 72 hours before billing. In writing. Monitor your card for 60 days after.
Is MEDVi Available in My State?
MEDVi operates in most U.S. states. ConsumerAffairs reports MEDVi serves 49 states with some restrictions: tablet products may not be available in Alabama and California, and some states require a video provider visit before prescribing. State availability and product availability change as licensing and regulatory rules evolve.
How We Verified This Page
We are an independent comparison resource for GLP-1 telehealth providers. We may receive compensation when you choose a provider through links on this page — at no additional cost to you. Compensation does not influence our editorial analysis. Providers are evaluated on verified evidence and reader fit.
Commercial facts verified (April 15, 2026)
- • MEDVi product navigation, pricing cards, advertised terms (glp.medvi.org)
- • MEDVi cancellation and refund policy (home.medvi.org)
- • NovoCare Pharmacy published self-pay price guide (novocare.com)
- • Ro Body membership and medication pricing (ro.co)
- • Ro Foundayo product and pricing (ro.co/weight-loss/foundayo)
- • Wegovy official pricing terms (WegovyTerms.com)
- • GoodRx Care telehealth pricing
Medical & regulatory facts verified
- • FDA warning letter to MEDVi, LLC dated February 20, 2026 (FDA.gov)
- • OASIS 4 clinical trial data for oral semaglutide (NEJM 2025)
- • Foundayo FDA approval (April 1, 2026) and ATTAIN-1 trial results
- • SNAC absorption technology mechanism
- • Standard Wegovy pill titration schedule (Wegovy.com)
Third-party trust signals
- • Trustpilot: 12,000+ reviews, 4.4–4.5/5
- • ConsumerAffairs: ~1,860 reviews, 3.4/5 (last update April 15, 2026)
- • LegitScript certification: active
- • Better Business Bureau profile: checked
Items we could not independently verify (flagged throughout this page):
- • MEDVi’s exact all-in checkout total for the branded Wegovy pill path
- • MEDVi’s specific pharmacy partner(s) for the branded path
- • Current exact state-by-state product availability
- • Current exact terms of MEDVi’s money-back guarantee
- • Exact scope of OpenLoop’s January 2026 cybersecurity incident
Continue Your Research
MEDVi Pills FAQ
Questions verified April 15, 2026
Still Not Sure Which GLP-1 Program Is Right for You?
Look — the options are confusing, the pricing structures don’t line up, and every provider markets themselves as the best. If you’re not sure whether MEDVi’s pill path, NovoCare direct, Ro, or something else fits your situation, we built a tool for exactly this moment.
Take our free 60-second matching quiz. We ask about your insurance status, needle preference, budget, morning routine, and state — then surface the specific program that fits. Personalized recommendation, no pressure.
Take the Free 60-Second Quiz
Get a Personalized GLP-1 Program Recommendation
Find My Best GLP-1 Match →